【Generic Name】   Hydrocortisone Sodium Succinate for Injection

【English Name】   Hydrocortisone Sodium Succinate for Injection

【Dosage Form】   Lyophilized powder injection

【Approval Number】   NFDA Approval H20084319;NFDA Approval H20084318

【Specification】   0.05g (C21H30O5)；0.1g (C21H30O5)

【Package】   10 bottles/box

【Indications】   It is used for the rescue of critically ill patients, such as toxic infections, anaphylactic shock, severe hypoadrenocorticism, connective tissue disease, severe bronchial asthma and other allergic diseases, and it can also be used for the prevention and treatment of acute graft rejection.